Guest Speaker: Kathy Meyer, Clinical Nurse Educator, Janssen

May 10, 2017 6:00 pm to 8:00 pm

Special Guest Speaker: Kathy Meyer, Clinical Nurse Educator, Janssen Pharmaceuticals will provide an update on Darzalex which was approved by the FDA to treat multiple myeloma on November 16, 2015. DARZALEX® is not chemotherapy.

DARZALEX® is a monoclonal antibody that works with your immune system. Monoclonal antibodies work by attaching themselves to multiple myeloma cells in your body and directly killing them, and/or signaling your immune system to destroy them. 

DARZALEX® finds and attaches to a protein called CD38, which is present on the surface of cells, including high numbers on myeloma cells.

For more information, please visit https://www.darzalex.com/

Address

PROSPECT PUBLIC LIBRARY, Community Meeting Room
17 Center Street
Prospect, CT 06712
United States